0001850995-21-000002.txt : 20210315 0001850995-21-000002.hdr.sgml : 20210315 20210315140111 ACCESSION NUMBER: 0001850995-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 EFFECTIVENESS DATE: 20210315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: U1 Bio, Inc. CENTRAL INDEX KEY: 0001850995 IRS NUMBER: 861521313 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-392266 FILM NUMBER: 21740994 BUSINESS ADDRESS: STREET 1: 18 BARTOL STREET #966 CITY: SAN FRANCISCO STATE: CA ZIP: 94133 BUSINESS PHONE: (336) 420-7881 MAIL ADDRESS: STREET 1: 18 BARTOL STREET #966 CITY: SAN FRANCISCO STATE: CA ZIP: 94133 D 1 primary_doc.xml X0708 D LIVE 0001850995 U1 Bio, Inc. 18 BARTOL STREET #966 SAN FRANCISCO CA CALIFORNIA 94133 (336) 420-7881 DELAWARE None None Corporation true 2021 David Nelles 18 Bartol Street #966 San Francisco CA CALIFORNIA 94133 Executive Officer Director Director and CEO Konstantinos Charizanis 18 Bartol Street #966 San Francisco CA CALIFORNIA 94133 Executive Officer Director COO and Director Biotechnology Decline to Disclose 06b false 2021-03-03 false true true SAFE - Simple Agreement for Future Equity false 25000 650000 450000 200000 false 9 0 0 0 Proceeds to be used for working capital false U1 Bio, Inc. David Nelles David Nelles CEO 2021-03-15